Senior insider sale
Chief Medical Officer at DENALI THERAPEUTICS INC. — senior position signals high conviction
$50.5K
3.74K shares
What this filing means
HO CAROLE plans to sell 3.74K shares of DENALI THERAPEUTICS INC. valued at approximately $50.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/13/2025ACC: 0001950047-25-005790
Officer· Chief Medical Officer
Since Aug 2018
3.74K
Shares to sell
$50.5K
Approx. market value
806.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
8/11/2025
806.00Total acquired806.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/11/2025 | Restricted Stock Units N/A | 806.00 | — |
| Total | 806.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.94K
Market value
$39.9K
8/12/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
806.00
Market value
$10.7K
8/13/2025
Total
Units
3.74K
Value
$50.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/12/2025 | 2.94K | $39.9K | — | Completed |
| Planned — Approximate Date | ||||
8/13/2025 | 806.00 | $10.7K | NASDAQ | Planned |
| Total | 3.74K | $50.5K | ||